Table 1.
Clinical characteristics.
| Overall population (n = 230) | Sex |
p value | ||
|---|---|---|---|---|
| Male (n = 188) | Female (n = 42) | |||
| Age, years | 63.1 ± 10.4 | 62.5 ± 10.4 | 65.7 ± 10.2 | 0.070 |
| Current smoker | 109 (47.4) | 106 (56.4) | 3 (7.1) | <0.001 |
| Hypertension | 141 (61.3) | 109 (58.0) | 32 (76.2) | 0.028 |
| Diabetes mellitus | 108 (47.0) | 88 (46.8) | 20 (47.6) | 0.924 |
| Hyperlipidaemia | 68 (29.6) | 54 (28.7) | 13 (31.0) | 0.774 |
| Chronic renal insufficiency | 7 (3.0) | 5 (2.7) | 2 (4.8) | 0.826 |
| Chronic cardiac insufficiency | 23 (10.0) | 18 (9.6) | 5 (11.9) | 0.864 |
| Prior coronary artery bypass grafting | 0 (0) | 0 (0) | 0 (0) | – |
| ST-segment elevation myocardial infarction | 12 (5.2) | 10 (5.3) | 2 (4.8) | 1.000 |
| Medication at the time of in-stent restenosis | ||||
| Aspirin | 219 (95.2) | 178 (94.7) | 41 (97.6) | 0.684 |
| Clopidogrel | 157 (68.3) | 129 (68.6) | 28 (66.7) | 0.806 |
| Ticagrelor | 56 (24.3) | 43 (22.9) | 13 (31.0) | 0.270 |
| Statin | 202 (87.8) | 165 (87.8) | 37 (88.1) | 0.953 |
| Fasting blood-glucose, mmol/L | 5.8 (5.0, 8.3) | 5.7 (5.0, 8.3) | 6.2 (5.1, 8.3) | 0.649 |
| LDL cholesterol, mg/dL | 1.8 (1.4, 2.3) | 1.8 (1.4, 2.3) | 1.9 (1.5, 2.4) | 0.359 |
Values are n (%) or mean and standard deviation or median (1st quartile, 3rd quartile). LDL: low-density lipoprotein.